28.06.2023 15:41:44
|
Roivant Q4 Loss Narrows, Better Than View
(RTTNews) - Shares of Roivant Sciences Ltd. (ROIV) are trading down on Wednesday morning after the company posted a narrow loss for the fourth-quarter, better than the Street estimates. In addition, the company's revenue more than doubled, above analysts' projections.
ROIV is trading down by 2.21 percent at $8.85 per share in morning trade on the Nasdaq.
For the fourth-quarter, loss stood at $33.617 million or $0.05 per share, compared with $270.062 million or $0.39 per share in loss of last year's quarter. On average, eight analysts, polled by Thomson Reuters had expected the company to post a loss of $0.36 per share. A narrow loss for the period was helped by a decrease in total operating expenses and income from discontinued operations. Total operating expenses moved down to $261.542 million from last year's $276.026 million.
Income from discontinued operations stood at $114.561 million, compared with zero earnings of previous year quarter.
Revenue was at $27.376 million, higher than $9.223 million of previous year. Analysts, on average, had expected ROIV to post revenue of $21.53 million, for the quarter.
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Roivant Sciencesmehr Nachrichten
Analysen zu Roivant Sciencesmehr Analysen
Aktien in diesem Artikel
Roivant Sciences | 10,40 | -3,17% |